| Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5 G Giannelli, J Falk-Marzillier, O Schiraldi, WG Stetler-Stevenson, ... Science 277 (5323), 225-228, 1997 | 1576 | 1997 |
| Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5 N Koshikawa, G Giannelli, V Cirulli, K Miyazaki, V Quaranta The Journal of cell biology 148 (3), 615-624, 2000 | 806 | 2000 |
| TGF‐β signalling and liver disease I Fabregat, J Moreno‐Cŕceres, A Sánchez, S Dooley, B Dewidar, ... The FEBS journal 283 (12), 2219-2232, 2016 | 655 | 2016 |
| Role of epithelial to mesenchymal transition in hepatocellular carcinoma G Giannelli, P Koudelkova, F Dituri, W Mikulits Journal of hepatology 65 (4), 798-808, 2016 | 585 | 2016 |
| Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses N Veronese, M Solmi, MG Caruso, G Giannelli, AR Osella, E Evangelou, ... The American journal of clinical nutrition 107 (3), 436-444, 2018 | 436 | 2018 |
| Laminin-5 with transforming growth factor-β1 induces epithelial to mesenchymal transition in hepatocellular carcinoma G Giannelli, C Bergamini, E Fransvea, C Sgarra, S Antonaci Gastroenterology 129 (5), 1375-1383, 2005 | 336 | 2005 |
| TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer L Caja, F Dituri, S Mancarella, D Caballero-Diaz, A Moustakas, ... International journal of molecular sciences 19 (5), 1294, 2018 | 333 | 2018 |
| Different cognitive frailty models and health-and cognitive-related outcomes in older age: from epidemiology to prevention F Panza, M Lozupone, V Solfrizzi, R Sardone, V Dibello, L Di Lena, ... Journal of Alzheimer's disease 62 (3), 993-1012, 2018 | 317 | 2018 |
| Blocking transforming growth factor–beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells E Fransvea, U Angelotti, S Antonaci, G Giannelli Hepatology 47 (5), 1557-1566, 2008 | 296 | 2008 |
| Transforming growth factor-β as a therapeutic target in hepatocellular carcinoma G Giannelli, E Villa, M Lahn Cancer research 74 (7), 1890-1894, 2014 | 294 | 2014 |
| Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinoma G Giannelli, C Bergamini, F Marinosci, E Fransvea, M Quaranta, L Lupo, ... International journal of cancer 97 (4), 425-431, 2002 | 277 | 2002 |
| Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study E Villa, R Critelli, B Lei, G Marzocchi, C Cammŕ, G Giannelli, P Pontisso, ... Gut 65 (5), 861-869, 2016 | 254 | 2016 |
| Transforming growth factor-β1 triggers hepatocellular carcinoma invasiveness via α3β1 integrin G Giannelli, E Fransvea, F Marinosci, C Bergamini, S Colucci, O Schiraldi, ... The American journal of pathology 161 (1), 183-193, 2002 | 240 | 2002 |
| Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells V Vergaro, F Scarlino, C Bellomo, R Rinaldi, D Vergara, M Maffia, ... Advanced drug delivery reviews 63 (9), 847-864, 2011 | 239 | 2011 |
| Down‐regulation of connective tissue growth factor by inhibition of transforming growth factor β blocks the tumor–stroma cross‐talk and tumor progression in hepatocellular … A Mazzocca, E Fransvea, F Dituri, L Lupo, S Antonaci, G Giannelli Hepatology 51 (2), 523-534, 2010 | 211 | 2010 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 204 | 2022 |
| MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis G Giannelli, R Erriquez, F Iannone, F Marinosci, G Lapadula, S Antonaci Clinical and experimental rheumatology 22 (3), 335-338, 2004 | 187 | 2004 |
| Oral frailty and its determinants in older age: a systematic review V Dibello, R Zupo, R Sardone, M Lozupone, F Castellana, A Dibello, ... The Lancet Healthy Longevity 2 (8), e507-e520, 2021 | 186 | 2021 |
| Targeting transforming growth factor (TGF)‐βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma E Fransvea, A Mazzocca, S Antonaci, G Giannelli Hepatology 49 (3), 839-850, 2009 | 185 | 2009 |
| A phase 2 study of galunisertib (TGF-β1 receptor type I inhibitor) and sorafenib in patients with advanced hepatocellular carcinoma RK Kelley, E Gane, E Assenat, J Siebler, PR Galle, P Merle, IO Hourmand, ... Clinical and translational gastroenterology 10 (7), e00056, 2019 | 184 | 2019 |
